
Addus HomeCare Corporation
Healthcare Providers and Services · USD
Price
$93.5
Cap
$1.7B
Earnings
4/4 beat
30d Trend
+2%
Near 52-week lows — potential value or falling knife
Target range: $102 – $160 (consensus: $139.46)
Consensus: Buy
Earnings history
Q4 2025
BEAT
1.77 vs 1.65
Q3 2025
BEAT
1.56 vs 1.53
Q2 2025
BEAT
1.49 vs 1.46
Q1 2025
BEAT
1.42 vs 1.33
Key macro factors
Ongoing Medicaid redeterminations are significantly impacting patient onboarding and retention in key states like Illinois, Texas, and New Mexico, leading to disruptions in census growth for Addus HomeCare.
Rising inflation and global economic uncertainties, partly driven by the Middle East conflict and potential IMF downgrades, could increase operational costs for Addus HomeCare's caregivers (e.g., fuel, wages) and potentially influence government healthcare funding upon which the company heavily relies.
Labor market dynamics, including a strong US job market with low unemployment, may lead to increased wage pressures for home healthcare caregivers, potentially affecting Addus HomeCare's profit margins if these costs cannot be fully offset by rate increases or efficiencies.
Addus HomeCare Corporation provides a range of home-based care services, including personal care, hospice, and home health, primarily to elderly, chronically ill, and disabled individuals in the United States.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
